Logotype for Nu Skin Enterprises Inc

Nu Skin Enterprises (NUS) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Nu Skin Enterprises Inc

Q3 2025 earnings summary

15 Nov, 2025

Executive summary

  • Q3 2025 revenue was $364.2 million, down 15.3% year-over-year, or 11.5% excluding Mavely, with EPS doubling to $0.34 from $0.17, reflecting disciplined execution amid macroeconomic pressures.

  • Customer, paid affiliate, and sales leader counts declined 10%, 13%, and 19% year-over-year, respectively, with sequential growth in Latin America and select segments.

  • Strategic focus is on launching the Prism iO intelligent wellness platform and expanding into India, with limited launches in Q4 2025 and full-scale rollouts in 2026.

  • Net income for Q3 2025 was $17.1 million, up from $8.3 million, driven by cost controls, lower tax rates, and the Mavely sale gain.

  • Sale of Mavely completed, impacting year-over-year comparisons and resulting in a $176.2 million pre-tax gain.

Financial highlights

  • Gross margin improved to 70.5% from 70.1% year-over-year; operating margin rose to 5.9% from 4.2%; selling expenses decreased to 35.8% of revenue from 39.0%.

  • Cash flow from operations was $27.7 million in Q3; cash and equivalents at $253.0 million at quarter-end.

  • Returned $3 million in dividends and repurchased $5 million in shares in Q3; $152.4 million remains under repurchase authorization.

  • Interest expense fell to $4.1 million from $6.5 million year-over-year.

  • Working capital as of September 30, 2025, was $293.7 million, up from $242.0 million at year-end 2024.

Outlook and guidance

  • Q4 2025 revenue projected between $365–$400 million, down 18% to 10% year-over-year, or 12% to 3% excluding Mavely; EPS guidance is $0.25–$0.35.

  • Full-year 2025 revenue guidance narrowed to $1.48–$1.51 billion, down 15%–13% (or 11%–9% excluding Mavely); adjusted EPS expected between $1.25 and $1.35.

  • No material revenue expected from Prism iO device sales in 2025; India market pre-opening in Q4 2025 with formal launch in H2 2026.

  • Capital expenditures for 2025 expected at $30–$35 million, focused on IT, plant expansion, and facility upgrades.

  • Focus remains on profitability, innovation, and growth acceleration in 2026, with Prism iO and India as key drivers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more